Prosthetic mitral valve thrombosis associated with new-onset hyperthyroidism due to Graves' disease: a case report.

IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
European Heart Journal: Case Reports Pub Date : 2025-04-10 eCollection Date: 2025-04-01 DOI:10.1093/ehjcr/ytaf184
Hasan Hadzalic, Selma Hasific, Luca Oechslin, Oliver Gaemperli, Patric Biaggi
{"title":"Prosthetic mitral valve thrombosis associated with new-onset hyperthyroidism due to Graves' disease: a case report.","authors":"Hasan Hadzalic, Selma Hasific, Luca Oechslin, Oliver Gaemperli, Patric Biaggi","doi":"10.1093/ehjcr/ytaf184","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Graves' disease is linked to a range of cardiovascular diseases. However, the association of new-onset hyperthyroidism with bioprosthetic valve thrombosis has not been reported yet.</p><p><strong>Case summary: </strong>We present the case of a 59-year-old Caucasian male who developed new-onset overt hyperthyroidism 6 years after undergoing bioprosthetic mitral valve replacement. Echocardiography revealed valve failure with high transmitral gradients caused by valve thrombosis. Following appropriate thyreostatic treatment and anticoagulation, his symptoms resolved, and subsequent evaluations showed resolution of the thrombus and normal valve function.</p><p><strong>Conclusion: </strong>In this case, the association of new-onset hyperthyroidism with bioprosthetic valve thrombosis is highly likely. Hyperthyroidism, characterized by a hypercoagulable state and hypofibrinolytic disorder, is known to be associated with thrombosis and thromboembolic events. As acute hyperthyroidism shows clinical features similar to endocarditis, an interdisciplinary approach, immediate appropriate diagnostic steps and management are crucial for a favourable outcome. This case suggests that hyperthyroidism should be considered in the differential diagnosis when evaluating new-onset valvular thrombosis.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 4","pages":"ytaf184"},"PeriodicalIF":0.8000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12159726/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal: Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjcr/ytaf184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Graves' disease is linked to a range of cardiovascular diseases. However, the association of new-onset hyperthyroidism with bioprosthetic valve thrombosis has not been reported yet.

Case summary: We present the case of a 59-year-old Caucasian male who developed new-onset overt hyperthyroidism 6 years after undergoing bioprosthetic mitral valve replacement. Echocardiography revealed valve failure with high transmitral gradients caused by valve thrombosis. Following appropriate thyreostatic treatment and anticoagulation, his symptoms resolved, and subsequent evaluations showed resolution of the thrombus and normal valve function.

Conclusion: In this case, the association of new-onset hyperthyroidism with bioprosthetic valve thrombosis is highly likely. Hyperthyroidism, characterized by a hypercoagulable state and hypofibrinolytic disorder, is known to be associated with thrombosis and thromboembolic events. As acute hyperthyroidism shows clinical features similar to endocarditis, an interdisciplinary approach, immediate appropriate diagnostic steps and management are crucial for a favourable outcome. This case suggests that hyperthyroidism should be considered in the differential diagnosis when evaluating new-onset valvular thrombosis.

Graves病致新发甲亢伴假体二尖瓣血栓1例
背景:格雷夫斯病与一系列心血管疾病有关。然而,新发甲状腺机能亢进与生物瓣膜血栓形成的关系尚未见报道。病例总结:我们报告一例59岁的白人男性,在接受生物二尖瓣置换术6年后出现新发显性甲状腺功能亢进。超声心动图显示由瓣膜血栓引起的高透射梯度瓣膜衰竭。经过适当的甲状腺抑制治疗和抗凝治疗,他的症状消退,随后的评估显示血栓消退,瓣膜功能正常。结论:在本病例中,新发甲状腺机能亢进与生物瓣膜血栓形成极有可能相关。甲状腺机能亢进以高凝状态和低纤溶障碍为特征,已知与血栓形成和血栓栓塞事件有关。由于急性甲状腺机能亢进表现出与心内膜炎相似的临床特征,因此跨学科的方法,立即适当的诊断步骤和管理对于良好的结果至关重要。本病例提示在评估新发瓣膜血栓形成时应考虑甲状腺功能亢进的鉴别诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Heart Journal: Case Reports
European Heart Journal: Case Reports Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.30
自引率
10.00%
发文量
451
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信